Literature DB >> 26562484

Health care utilization and costs for children and adults with duchenne muscular dystrophy.

Lucinda J Teoh1, Elizabeth A Geelhoed2, Klair Bayley2, Helen Leonard3, Nigel G Laing2.   

Abstract

INTRODUCTION: Duchenne muscular dystrophy (DMD) is an incurable neuromuscular disorder of childhood. Healthcare, caregiving, and other resource needs of affected individuals are thought to be substantial; however, the economic burden associated with DMD has not yet been assessed specifically in Australia.
METHODS: Australian households with a child with DMD were asked to complete a cross-sectional survey. Data were collected on annual resource utilization including hospital and medical services, equipment, home modifications, informal care, and working days lost.
RESULTS: Mean healthcare costs were found to be $10,046 Australian dollars per affected individual and were markedly higher than average Australian health expenditures at each age group. The mean total cost was $46,700 (median $32,300), with healthcare costs contributing 22% of total costs.
CONCLUSIONS: The annual economic cost of DMD was found to be high, reflecting a significant socioeconomic burden, especially in boys who reach adulthood, where household resource use and caregiving burden is highest. Muscle Nerve 53: 877-884, 2016.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  DMD; Duchenne muscular dystrophy; burden; cost; healthcare; muscular dystrophy; resource use

Mesh:

Year:  2016        PMID: 26562484     DOI: 10.1002/mus.24965

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Creation of a novel algorithm to identify patients with Becker and Duchenne muscular dystrophy within an administrative database and application of the algorithm to assess cardiovascular morbidity.

Authors:  Jonathan H Soslow; Matthew Hall; W Bryan Burnette; Kan Hor; Joanne Chisolm; Christopher Spurney; Justin Godown; Meng Xu; James C Slaughter; Larry W Markham
Journal:  Cardiol Young       Date:  2019-01-26       Impact factor: 1.093

2.  Health Care Use of Cardiac Specialty Care in Children With Muscular Dystrophy in the United States.

Authors:  Erika J Mejia; Kimberly Y Lin; Oluwatimilehin Okunowo; Katherine A Iacobellis; Susan E Matesanz; John F Brandsema; Carol A Wittlieb-Weber; Hannah Katcoff; Heather Griffis; Jonathan B Edelson
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

3.  Labor market participation and productivity costs for female caregivers of minor male children with Duchenne and Becker muscular dystrophies.

Authors:  Rieza H Soelaeman; Michael G Smith; Kashika Sahay; J Mick Tilford; Dana Goodenough; Pangaja Paramsothy; Lijing Ouyang; Joyce Oleszek; Scott D Grosse
Journal:  Muscle Nerve       Date:  2021-10-18       Impact factor: 3.852

4.  The New Zealand Neuromuscular Disease Patient Registry; Five Years and a Thousand Patients.

Authors:  Miriam J Rodrigues; Gina L O'Grady; Graeme Hammond-Tooke; Alexa Kidd; Donald O Love; Ronelle K Baker; Richard H Roxburgh
Journal:  J Neuromuscul Dis       Date:  2017

Review 5.  Incomplete description of the current body of evidence of the health economics of Duchenne muscular dystrophy.

Authors:  Erik Landfeldt; Hanns Lochmüller; Peter Lindgren
Journal:  Orphanet J Rare Dis       Date:  2019-04-02       Impact factor: 4.123

Review 6.  The adult multidisciplinary respiratory neuromuscular clinic.

Authors:  Neeraj M Shah; Patrick B Murphy; Georgios Kaltsakas
Journal:  Breathe (Sheff)       Date:  2020-09

Review 7.  Cost-of-illness studies in rare diseases: a scoping review.

Authors:  Lidia García-Pérez; Renata Linertová; Cristina Valcárcel-Nazco; Manuel Posada; Inigo Gorostiza; Pedro Serrano-Aguilar
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

8.  The Relationship between Obesity and Clinical Outcomes in Young People with Duchenne Muscular Dystrophy.

Authors:  Natassja Billich; Justine Adams; Kate Carroll; Helen Truby; Maureen Evans; Monique M Ryan; Zoe E Davidson
Journal:  Nutrients       Date:  2022-08-12       Impact factor: 6.706

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.